Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle

被引：31

作者：

Chen, Yao ^{[1
,5
]}

Xu, Mengjiao ^{[1
]}

Guo, Yi ^{[1
]}

Tu, Keyao ^{[2
]}

Wu, Weimin ^{[1
]}

Wang, Jianjun ^{[1
]}

Tong, Xiaowen ^{[1
]}

Wu, Wenjuan ^{[3
]}

Qi, Lifeng ^{[2
,6
]}

Shi, Donglu ^{[2
,4
]}

机构：

[1] Tongji Univ, Sch Med, Dept Obstet & Gynaecol, Tongji Hosp, Shanghai 200065, Peoples R China

[2] Tongji Univ, Sch Med, Inst Translat Nanomed, Shanghai East Hosp,Inst Biomed Engn & Nano Sci, Shanghai 200092, Peoples R China

[3] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Lab Med, Shanghai 200123, Peoples R China

[4] Univ Cincinnati, Dept Mech & Mat Engn, Coll Engn & Appl Sci, Mat Sci & Engn Program, Cincinnati, OH 45221 USA

[5] Nanjing Med Univ, Affiliated Hosp 2, 121 Jiangjiayuan Rd, Nanjing 210011, Jiangsu, Peoples R China

[6] Shanghai Foxgene Med Co LTD, Room 501,Fudan Sci Technol Pk,11 Guotai Rd, Shanghai 200092, Peoples R China

来源：

NANOTECHNOLOGY | 2017年 / 28卷 / 02期

关键词：

chimera; Notch3; Au-Fe3O4; nanoparticles; multi-drug resistance; ovarian cancer; APTAMER-SIRNA CHIMERAS; ELONGATION-FACTOR; 2; IN-VITRO; GENE; INHIBITION; NOTCH3; GROWTH; ANGIOGENESIS; APOPTOSIS; VEGF(165);

D O I：

10.1088/0957-4484/28/2/025101

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

Efficient delivery of small interfering RNAs (siRNAs) to the targeted cells has remained a significant challenge in clinical applications. In the present study, we developed a novel aptamer-siRNA chimera delivery system mediated by cationic Au-Fe3O4 nanoparticles (NPs). The chimera constructed by VEGF RNA aptamer and Notch3 siRNA was bonded with heterogeneous Au-Fe3O4 nanoparticles by electrostatic interaction. The obtained complex exhibited much higher silencing efficiency against Notch3 gene compared with chimera alone and lipofectamine-siRNA complex, and improved the antitumor effects of the loaded chimera. Moreover, the efficient delivery of the chimera by Au-Fe3O4 NPs could reverse multi-drug resistance (MDR) of ovarian cancer cells against the chemotherapeutic drug cisplatin, indicating its potential capability for future targeted cancer therapy while overcoming MDR.

引用

页数：13

共 37 条

[21] Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin [J].

Park, Joon Tae ;

Chen, Xu ;

Trope, Claes G. ;

Davidson, Ben ;

Shih, Ie-Ming ;

Wang, Tian-Li .

AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (03) :1087-1094

[22]

Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224

[23] RNA-mediated gene silencing [J].

Pickford, AS ;

Cogoni, C .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (05) :871-882

[24] Inhibition of glioma proliferation and migration by magnetic nanoparticle mediated JAM-2 silencing [J].

Qi, Lifeng ;

Liu, Jing ;

Zhu, Haiyan ;

Li, Zhuoquan ;

Lu, Kun ;

Li, Tian ;

Shi, Donglu .

JOURNAL OF MATERIALS CHEMISTRY B, 2014, 2 (41) :7168-7175

[25] Cell-Penetrating Magnetic Nanoparticles for Highly Efficient Delivery and Intracellular Imaging of siRNA [J].

Qi, Lifeng ;

Wu, Lixia ;

Zheng, Shu ;

Wang, Yilong ;

Fu, Hualin ;

Cui, Daxiang .

BIOMACROMOLECULES, 2012, 13 (09) :2723-2730

[26] 2′-fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165) -: Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain [J].

Ruckman, J ;

Green, LS ;

Beeson, J ;

Waugh, S ;

Gillette, WL ;

Henninger, DD ;

Claesson-Welsh, L ;

Janjic, N .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20556-20567

[27] Angiogenesis as a target for the treatment of ovarian cancer [J].

Shaw, Danielle ;

Clamp, Andrew ;

Jayson, Gordon C. .

CURRENT OPINION IN ONCOLOGY, 2013, 25 (05) :558-565

[28]

Sivaprasad S, 2008, CLIN OPHTHALMOL, V2, P339

[29] Synthesis of PEGylated Ferrocene Nanoconjugates as the Radiosensitizer of Cancer Cells [J].

Tian, Jian ;

Chen, Jie ;

Ge, Cuicui ;

Liu, Xu ;

He, Jinlin ;

Ni, Peihong ;

Pan, Yue .

BIOCONJUGATE CHEMISTRY, 2016, 27 (06) :1518-1524

[30] A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders [J].

Wang, Chuang-Wei ;

Chung, Wen-Hung ;

Cheng, Yi-Fang ;

Ying, Nien-Wen ;

Peck, Konan ;

Chen, Yuan-Tsong ;

Hung, Shuen-Iu .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (03) :713-+

← 1 2 3 4 →